Almac’s Clinical Trial Workshop Series to return in 2012
March 15, 2012
Almac will be hosting a series of complementary ‘lunch and learn’ style workshops across Europe and the US this spring tailored towards clinical trial / outsourcing professionals from Pharmaceutical and Biotech companies. The content of the workshops, which are titled ‘“Blinding Techniques and Analytical Support for Clinical Trials”, will provide an informative and educational insight into the challenges involved in Phase I-III trial encapsulation, blinding, packaging, and labeling as well as the associated analytical considerations in this area.
Robert Dunlop, Managing Director at Almac commented: “The workshops are designed to promote learning and encourage dialog amongst members of the clinical trial profession. Attendees can share experiences, discuss common challenges, and ultimately take away with them methods for overall success in clinical trials.“
As with previous workshops delivered by Almac, the content demonstrates how the integrated service offerings from the Almac Group deliver a more streamlined supply chain network in an industry wherein time and resources are limited.
The venues and dates for this year’s workshops can be found below.
US dates / locations
EU dates / locations
To register for an event near you, visit the registration sites here. Seats are limited, and registration is required to secure your place. For more information about the Almac Group, please visit www.almacgroup.com or e-mail firstname.lastname@example.org
Notes to Editors
The Almac Group provides a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS® technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors. The company employs over 3,300 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania,North Carolina and California.